33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • LSD1 inhibition restores MHC class I expression and augments the anti-tumor response of immune checkpoint blockade in small cell lung cancer
    Meeting Abstract

    Sen, T.; Nguyen, M. N.; Taniguchi, H.; Chow, A.; De Stanchina, E.; Rudin, C. M.
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • KEYNOTE-B98: Phase Ib/II study of pembrolizumab plus investigational agents as second-line treatment for anti-PD-1/PD-L1-refractory extensive-stage small cell lung cancer (ES-SCLC)
    Meeting Abstract

    Lai, W. C. V.; Ahn, M. J.; Shentzer, T.; Kowalski, D.; Cho, B. C.; Schmid, S.; Jové, M.; Huang, M.; Zhao, B.; El-Osta, H.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Phase I dose escalation of IMC-C103C, a CD3xMAGE-A4 T-cell receptor (TCR) bispecific protein
    Meeting Abstract

    Davar, D.; Sweis, R. F.; Blumenschein, G. Jr; Gutierrez, R.; Melero, I.; Chen, H. A.; Thistlethwaite, F.; Moore, K. N.; Segal, N. H.; Garralda, E.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Promoting functional persistence in solid tumor CAR T-cell therapy: Mesothelin-targeted CAR (M28z1XXPD1DNR) with T-cell intrinsic PD1 dominant negative receptor
    Meeting Abstract

    Adusumilli, P. S.; Amador, A. M.; Chintala, N.; Hou, Z.; Offin, M.; Pineda, J.; Senechal, B.; Quach, H. T.; Bellis, R.; Banerjee, S.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Neoantigen-reactive CD8 T-cells experience broadened and activated recognition profile following PD-L1 blockade and 1000-fold neoantigen-specific expansion using ImmPACT scaffolds
    Meeting Abstract

    Sejerø Holm, J.; Funt, S. A.; Tvingsholm, S. A.; Borch, A.; Bajorin, D. F.; Reker Hadrup, S.
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Eosinophilic gastroenteritis presenting as hypoalbuminemia
    Meeting Abstract

    Sharma, K.; Laszkowska, M.; Satish, D.
    American Journal of Gastroenterology (2021)

    Fulltext@MSK | Save
  • Perioperative management of a lactating cancer patient undergoing surgical placement and removal of an Iodine-125 brachytherapy plaque for uveal melanoma
    Meeting Abstract

    Rieth, E.; Barnett, K.; Simon, J.
    Anesthesia and Analgesia (2021)

    Fulltext@MSK | Save
  • Dynamic circulating tumour DNA (ctDNA) response to neoadjuvant (NA) atezolizumab (atezo) and surgery (surg) and association with outcomes in patients (pts) with NSCLC
    Meeting Abstract

    Kris, M. G.; Grindheim, J. M.; Chaft, J. E.; Lee, J. M.; Johnson, B. E.; Rusch, V. W.; Bunn, P. A.; Pass, H.; Schum, E.; Carlisle, J.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Nivolumab (NIVO) + ipilimumab (IPI) versus chemotherapy (chemo) as first-line (1L) treatment for advanced NSCLC (aNSCLC) in CheckMate 227 part 1: Efficacy by KRAS, STK11, and KEAP1 mutation status
    Meeting Abstract

    Ramalingam, S. S.; Balli, D.; Ciuleanu, T. E.; Pluzanski, A.; Lee, J. S.; Schenker, M.; Caro, R. B.; Lee, K. H.; Bartolucci, R.; Audigier-Valette, C.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Using ultrasound as a tool for airway assessment and predicting difficult intubation in patients undergoing cancer surgery
    Meeting Abstract

    Lewis, A.; Dabo-Trubelja, A.; Guzman-Seda, N. M.
    Anesthesia and Analgesia (2021)

    Fulltext@MSK | Save